Skip to content

Influence of locomotion therapy with the wearable cyborg HAL on bladder and bowel function in acute and chronic SCI patients

Influence of locomotion therapy with the wearable cyborg HAL on bladder and bowel function in acute and chronic SCI patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023156
Enrollment
35
Registered
2020-10-05
Start date
2013-09-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G82 S14 S24 S34

Interventions

Group 1: Patients with acute or chronic paraplegia are retrospectively surveyed using questionnaires about their bladder and bowel function before and after exoskeletal training.

Sponsors

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with acute ( 1 year) spinal cord lesion.

Exclusion criteria

Exclusion criteria: Cardiopulmonary comorbidities, decubitus on the lower extremity / rump region, infections, osteoporosis, thrombosis / embolism in the past, contractures or severe spasticity of the lower extremity, body weight> 100 kg. Epilepsy, the presence of electronic medical devices that cannot be removed (e.g. pacemakers).

Design outcomes

Primary

MeasureTime frame
After exoskeletal training, the patients were asked to answer questionnaires on the condition of bladder and bowel function before and after training.

Secondary

MeasureTime frame
Upon receipt of all completed questionnaires.

Countries

Germany

Contacts

Public ContactAlexis Brinkemper

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH

alexis.brinkemper@bergmannsheil.de02343026918

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026